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Abstract
Main Objective: The study sought to identify the presentation patterns o f invasive uterine cancer o f the cervix 
(CaCx) in Zimbabwe in terms o f histology, stage o f the disease, ages o f patients and socio-economic status. 
Design: Retrospective study from 1998 to 2010.
Subjects: All patients who registered for the first time with invasive CaCx over a systematically selected 
sample period o f four years (1998,2002,2006 & 2010).
Setting: The main referral Radiotherapy and Oncology centre in Harare the capital city o f Zimbabwe.
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Results: Majority o f patients (91.75%) presented with squamous cell carcinoma, 5.5% presented with 
adenocarcinomas and 2.75% presented with other types of histology. Late presentation was noted with the 
majority of the patients (89%) presenting with stage IIB and above. The common ages o f patients at 
presentation were between 40 to 60 years. The majority o f the patients (59.5%) were of low socio-economic 
status.
Conclusion: In the developed countries CaCx is reducing in frequency, presentation tends to be early, 
treatment effective and there is decreasing mortality rate from this disease. However in developing countries 
the situation is not as positive and the disease remains a major concern. This is shown by the presentation 
pattern o f patients with invasive CaCx in Zimbabwe. The patients are shown to present with late stage disease 
o f the squamous cell type, primarily in the age ranges o f 40 to 60 years and with the majority o f the patients 
belonging to the low socio-economic status group.
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Introduction
Cancer o f  the uterine cervix is the second most 
common cancer among women worldwide with a high 
incidence in Sub-Saharan Africa.1 In developing 
countries such as Zimbabwe invasive cancer o f the 
cervix (CaCx) is the most common cancer in females 
and also the leading cause o f cancer related deaths in 
women.2 The American Cancer Society3 estimated that 
12.710 million new cases o f  invasive CaCx were going 
to be diagnosed in 2011 and about 4.290 million 
women were going to die with invasive CaCx. The 
same author reported that there is a significant decrease 
in incidence and mortality rate o f invasive CaCx in 
developed countries over the past three decades as 
compared to the developing countries. This was 
attributed to available options o f disease prevention 
with the possibility o f early diagnosis o f the disease due 
to effective screening and accessibility to effective 
treatment procedures in developed countries. To this 
end it has been noted that women living in developed 
countries have a 208% greater chance o f  being 
successfully treated when compared with women in 
less developed countries.4
In Zimbabwe the ratio o f  patients with CaCx in 
relation to the total number o f  female patients with 
cancer registered per year for the periods 1990-2004 
showed an upward trend.5 While many Zimbabwean 
women are dying with invasive CaCx there are reports 
that with effective screening and Human Papilloma 
virus (HPV) vaccination in women, the incidence o f  
invasive CaCx can be reduced to negligible levels 
making it a “preventable disease”7 It has been identified 
that there is late presentation for treatment in most 
invasive CaCx patients in Zimbabwe due to inadequate 
CaCx screening resulting in poor prognosis and high 
mortality rates among CaCx patients in Zimbabwe.5 4
This study aimed at determining the presentation 
patterns o f  invasive CaCx in Zimbabwe in terms o f  
histology, stage o f  the disease, ages o f  patients and 
socio-economic status.
Materials and Methods
This was a retrospective study o f  data gathered from
files o f  patients with invasive CaCx for the period 1998 
to 2010 to reflect information on their first registration. 
A systematically selected sample o f  4 years was used 
with 1998 as base year (1998; 2002; 2006; 2010). The 
Oncology and Radiotherapy Centre at Parirenyatwa 
group o f hospitals was the site o f  study.
Ethics
Permission was sought from the Clinical Director for 
Parirenyatwa Group o f Hospitals through the Head o f  
Department o f  the Parirenyatwa Oncology and 
Radiotherapy centre. The research proposal together 
with the letter o f permission from the Head o f  
Department o f the Parirenyatwa Oncology and 
Radiotherapy centre were reviewed by The Cape 
Peninsula University o f Technology (CPUT) Health 
and Wellness Research Ethics Committee to confirm 
that the proposed research process had taken into 
account the required ethical principles and an approval 
certificate was issued on 12 October 2010 with 
reference number REC-230408-04.
Patients' identification was kept confidential by using 
codes instead o f  actual patient names or file numbers.
Statistics
All statistical operations which involved construction 
o f  graphs and trend analysis were done using Microsoft 
excel package. In trend analysis an R2 value o f  less than
0.1 was considered insignificant.
Results
The data collected during the study were tabulated and 
analysed to bring out the presentation patterns o f  
invasive CaCx in Zimbabwe in terms o f  histology, 
stage o f  disease, age o f  patients, and the socioeconomic 
status o f  the patients.
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Figure I: Registeredpatients (1998-2010). Figure III: Histology 1998.
n =  871
The number of newly registered patients for 1998, 
2002, and 2006 was almost constant and then there was 
an outlier in 2010 of a frequency o f336. In order to find 
out whether the change was abrupt or was gradual 
during the years between 2006 and 2010 another line 
graph (Figure II) was drawn with the number of 
patients who registered in 2007, 2008 and 2009 
included.
Figure II: Registered patients 1998-2010 (2007, 2008, 
and 2009 included).
Figure IV: Histology 2002.
85%
■ see ■ adenocarcinoma Bother
Figure V: Histology 2006.
The frequencies for 2007 (189), 2008 (174) and 2009 
(218) were within the same range with the other 3 years 
(1998, 2002 and 2006), and 2010 still remained an 
outlier with 336 patients being registered.
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2010{N= 231)
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Figure VI: Histology 2010
91%
■ see ■ adenocarcinoma Bother
Squamous cell carcinoma (SCC) had the highest 
percentage frequency in all the four years with 96% in 
1998,85% in 2002,95% in 2006 and 91% in 2010. The 
occurrence of Adenocarcinoma had an occurrence of 
3% for 1998, 7% for 2002, 5% for 2006 and 7% for 
2010.
Figure VII: Histology 1998-2010.
Trendlines: SCC y = -0.005x + 0.93 R2 = -0.0167
Adenocarcinoma y = 0.01 x + 0.03 R2= 0.4545
Others: y = 0.005x + 0.04 R2= 0.0323
category for stage IIIA disease there were 107 patients 
(16%), those with stage IIIB disease were 162 (24%). 
The number of patients with stage III (A+B) disease 
was 109 (16%) and those with stage IV disease were 65 
(10%). The majority (89%) of the patients presented 
late with stage IIB and above.
Figure VIII: Disease stages IIIA and below (1998- 
2010) .
■ IA&IB 4N 1IA  4fr>lIB "Mb IIIA
-Linear (1A&1B)----- Linear (I1A) ------Linear (IIB) ------ Linear (IUA)
Trendlines: IA&IB: 
IIA: 
IIB: 
IIIA:
y=-0.003x + 0.03 
y=-0.001x+0.095 
y=-0.003x + 0.23 
y=0.039x + 0.0055
R=0.0947 
R’=0.001 
R:=0.0035 
R3=0.6745
Stage IIIA trend line shows an upward trend with an R2 
value of 0.6745. Category for stages (IA & IB) has a 
slow downward trend with an R2 value of 0.0947. The 
R2 values for the category for stages IIA and IIB are not 
statistically significant.
Figure IX: Disease stages IIIB to IV (1998-2010).
■ * ■ !!! (A>B) ------- Linear (IIIB) --------Linear (HIA-B) ------- Lincar(IV)
There is a weak upward trend for adenocarcinoma type 
with an R2 value of 0.4545. The R2 values for the 
squamous cell carcinoma type and other histologies are 
so small that they are statistically insignificant.
Stage of the disease
The FIGO staging system was used in staging invasive 
CaCx. In all the analyses stages IA and IB were 
combined to form one category because very few 
patients presented with such early stages at the study 
centre. The total number of patients with recorded 
stages of invasive CaCx stages for the four years (1998, 
2002,2006 and 2010) is 675. Stages IA and IB category 
had 15 patients (2%), 61 patients (9%) had stage IIA 
disease, 156 patients (23%) had stage IIB CaCx. In the
Trendlines: IIIB: y=-0.057x + 0.39 R3=0.9627
III(A+B): y=0.005x + 0.155 R =0.0847
IV: y=0.02x + 0.045 R3=0.2899
The trend lines for stage IV shows a slow upward trend 
with an R2 value of 0.2899. The R2 value (0.0847) for 
stage 111 (A+B) is not statistically significant. Stage 
IIIB trend line shows a strong downward trend with an 
R2 value o f0.9627.
Ages of patients at presentation.
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In 1998 the minimum age (22 years) was in the (20 to < 
30 years) age group and the maximum age (88years) 
was in the (80 to < 90 years) age group. The mean, 
median and modal ages for 1998 were 48.8 years, 48 
years, and 45 years respectively. The mean, median and 
mode all lie in the same age group (40 to < 50 years).
In 2002 (figure XI) the minimum age (23 years) was 
in the (20 to < 30 years) age group and the maximum 
age (88 years) was in the (80 to < 90 years) age group. 
The mean, median and modal ages were 51 years, 48 
years and 42 years. The mean age lies in the (50 to < 60 
years) age group and the median and modal ages lie in 
the (40 to < 50 years) age group.
Figure XII shows the age distribution for the year 
2006. The minimum age (23 years) was in the (20 to < 
30 years) age group and the maximum age (83 years) 
was in the (80 to < 90 years) age group. The mean, 
median and modal ages were 50.1 years, 50 years and 
53 years respectively. All the averages (mean, median 
and modal ages) lie in the (50 to < 60 years) age group.
The age distribution for patients who were registered 
in 2010 is shown in figure XIII. The minimum age (28 
years) was in the (20 to < 30) years age group and the 
maximum age (88 years) was in the (80 to < 90 years) 
age group. The mean, median and modal ages were 
52.6 years, 50.5 years and 42 years respectively. The 
mean and the median belong to the (50 to < 60 years) 
age group and the modal age group was (40 to < 50 
years).
Table I: Measures ofcentral tendency and dispersion.
Measures 1998 2002 2006 2010
Mean age 48.8 years 51 years 50.1 years 52.6 years
Median age 48 years 48 years 50 years 50.5 years
Modal age 45 years 42 years 53 years 42 years
Minimum age 22 years 23 years 23 years 28 years
Maximum age 88 years 88 years 83 years 88 years
Standard deviation 12.5 14.4 11.8 13.7
Skewness 0.36 0.67 028 0.37
FigureXIV: Line graphs and linear trend lines fo r  ages 
o f  patients (20 to <60 years).
3<>C'>
Years
u> u> J o  % . . a '  -‘• ig f d u i-.. %  \ l .i>
Trendlines: 20 to <30 years: y =-0.004x 0.05 R:=0.4
30 to <40 years: y = -0.0l2x + 0.23 R:=0.4
40 to <50 years: y = -0.02x + 0.36 R2=0.4545
50 to <60 years: y = 0.02x + 0.l8 R2=0.1923
Figure XV: Line graphs and linear trend lines fo r  ages 
o f  patients (60 to <90 years).
....
Years
The general appearance o f  the trend lines demonstrate a 
downward trend for all the young aged group o f 
patients o f ages (20 to < 30 years), (30 to < 40 years) 
and (40 to < 50 years) and an upward trend for the 
remainder o f  the age groups (50 to < 60 years), (60 to < 
70 years), (70 to < 80 years) and (80 years to < 90 
years).
Socio-econom ic status
Three categories were used to describe socio-economic 
status o f  patients where those who were employed and 
resided in the cities were defined as o f a high socio­
economic status, those not employed and residing in 
the city or employed and residing in the rural areas were 
defined as o f  a middle socio-economic status and those 
unemployed and residing in rural areas were defined as 
belonging to the low socio-economic status group.10
The majority (113) 66% o f the patients belonged to 
the low socieconomic status in 1998. In 2002 the 
majority (69) 52% were o f  the middle socieconomic 
status. In 2006 (76) 58% and 2010 (149) 65% were the 
majority and these belonged to the low socio-economic 
status group.
Figure XVI: Line graphs and linear trend lines fo r  
patients ’socio-economic status.
A weak downward trend was noted for those in the 
middle socio-economic status group and a strong 
upward trend was noted for those in the high socio­
economic status group.
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Discussion
The number o f patients registering with invasive CaCx 
in Harare Zimbabwe remained almost constant in 1998 
(182), 2002 (172) and 2006 (181). The sudden increase 
in 2010 could not be attributed to population changes in 
the country since the population figures for 2010 (11.7 
million) were lower than the population figures o f2006 
(12.8 million)."'12
However according to the Zimbabwe Ministry o f  
Health and Child Welfare (ZMHCW)10 the health 
delivery system in Zimbabwe is linked to the socio­
economic condition o f the country.One o f  the reasons 
why there was such a sudden increase in the number o f  
patients registering with invasive CaCx in 2010 could 
be that in the previous decade Zimbabwe experienced 
severe economic difficulties. The situation worsened in 
2008 which resulted in the closure o f some public 
hospitals and even those hospitals that remained 
functional operated at very low capacity. As a result 
most people who required medical attention suffered at 
home without treatment.10 In 2009 the economic 
situation began to improve due to the introduction o f  
the multicurrency” and this could have contributed 
towards the sudden increase in the number o f patients 
who registered in 2010. This conclusion is further 
confirmed by the Association o f Health Funders o f  
Zimbabwe (AFHoZ) 14 which pointed out that the 
medical insurance bill for 2010 was far higher than any 
bill that was recorded for the previous ten years. After 
incorperating the figures for the three years between 
2006 and 2010 an upward linear trend with a rate o f  
increase o f  19.54 was recorded which is in line with 
what was reported in Sub-Saharan Africa where an 
increase in the number o f  patients registering with 
invasive CaCx was observed.1516 This is in sharp 
contrast to what is happening in developed countries 
where invasive CaCx is becoming uncommon due to 
effective screening, early detection and HPV 
vaccinations.7
The majority o f the patients (89%) presented with late 
stage disease from stage IIB and above and an upward 
trend was recorded for disease stages IIIA and above 
with the exception o f stage IIIB. The expected survival 
rate is reduced from 90% for stage I disease to 50% and 
10% for stages II and III respectively.17 This then 
translates in high mortality rates for invasive CaCx 
patients in sub Saharan Africa. 218 In Zimbabwe the 
situation is reported to be worse than the other 
surrounding countries due to the inadequacy o f  
facilities for screening and prevention.9 "J9 It was 
recommended that the governments o f  the sub Saharan 
Africa need to recognise cancer as a major public 
health concern and allocate resources for screening, 
prevention, treatment and research.20
It was noted that there is a downward trend o f  the 
number o f young (below 50years) women presenting 
with CaCx. This is in contrast with the argument by 
Sekerime and Gray20 who after carrying out a study in
Uganda concluded that the prevalence o f Human 
immuno-deficency virus (HIV) has resulted in an 
increase o f  the number o f younger women (mean age o f  
35.8 years) presenting with invasive CaCx.
It is also important to note that during the 
period(1998- 2010) the difficult economic situation 
resulted in a number o f  people including women, 
emigrating. Also those that could, went to South Africa 
or Botswana for treatment o f  cancer o f the uterine 
cervix. This affected the validity o f  the trend analysis as 
the population at risk did not remain the same but 
changed by an unknown proportion.
Conclusion
The majority o f  the patients (91.75%) presented with 
squamous cell carcinoma (SCC), 5.5% presented with 
adenocarcinoma and 2.75% with other histologies. It 
was found that (89%) o f  women presented with late 
stage disease (stage IIB and above). A downward trend 
was observed for stages IIB and below and for stages 
IIIA and above with the exception o f  stage IIIB, an 
upward trend was noted. The most common age o f  
patients at presentation was between 40 to 60 years. 
Trend analysis indicated that there is a decrease in the 
number o f  patients presenting at ages below 50 years 
while those above 50 years are increasing. The majority 
(59.5%) o f  the patients were o f  low socio-economic 
status.
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